Non-competitive pharmacologic chaperones developed through the Site-directed Enzyme Enhancement Therapy (SEE-Tx) technology for the treatment of rare genetic and neurodegenerative diseases

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

35449.1 IP-LS

Projekttitel

Non-competitive pharmacologic chaperones developed through the Site-directed Enzyme Enhancement Therapy (SEE-Tx) technology for the treatment of rare genetic and neurodegenerative diseases

Projekttitel Englisch

Non-competitive pharmacologic chaperones developed through the Site-directed Enzyme Enhancement Therapy (SEE-Tx) technology for the treatment of rare genetic and neurodegenerative diseases

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung		-	-
Abstract		-	-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Deutsch)	Non-competitive pharmacologic chaperones developed through the Site-directed Enzyme Enhancement Therapy (SEE-Tx) technology for the treatment of rare genetic and neurodegenerative diseases
Kurzbeschreibung (Englisch)	Non-competitive pharmacologic chaperones developed through the Site-directed Enzyme Enhancement Therapy (SEE-Tx) technology for the treatment of rare genetic and neurodegenerative diseases
Abstract (Deutsch)	In cellulo investigation of the mechanisms of action of non-competitive pharmacological chaperones that can recover misfolded mutant proteins and reduce the toxic accumulation of substrates therefore filling high unmet medical needs in the treatment of rare genetic and neurodegenerative disorders.